These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17173828)

  • 1. [Porokeratosis in a patient with dermatomyositis].
    Monteagudo-Sánchez B; Ginarte M; Durana C; Labandeira J; de las Heras C; Cacharrón JM
    Actas Dermosifiliogr; 2006 Dec; 97(10):650-2. PubMed ID: 17173828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of disseminated superficial actinic porokeratosis subsequent to renal transplantation.
    Matsushita S; Kanekura T; Kanzaki T
    J Dermatol; 1997 Feb; 24(2):110-2. PubMed ID: 9065706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated superficial porokeratosis.
    Brauer JA; Mandal R; Walters R; Solomon G; Kundu RV; Strober BE
    Dermatol Online J; 2010 Nov; 16(11):20. PubMed ID: 21163171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated superficial porokeratosis in a patient with cholangiocarcinoma: a paraneoplastic manifestation?
    Torres T; Velho GC; Selores M
    An Bras Dermatol; 2010; 85(2):229-31. PubMed ID: 20520941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pustular porokeratosis.
    Miller DD; Ruben BS
    J Cutan Pathol; 2009 Nov; 36(11):1191-3. PubMed ID: 19508498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of edematous dermatomyositis.
    Mroué KH; Sharara NH; Rbeiz JG; Arayssi TK
    J Rheumatol; 2003 Dec; 30(12):2722-3. PubMed ID: 14719223
    [No Abstract]   [Full Text] [Related]  

  • 7. Eruptive disseminated porokeratosis associated with corticosteroid-induced immunosuppression.
    Bednarek R; Ezra N; Toubin Y; Linos K; Mousdicas N
    Clin Exp Dermatol; 2015 Oct; 40(7):753-6. PubMed ID: 25800103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid development of disseminated superficial porokeratosis after transplant induction therapy.
    Fields LL; White CR; Maziarz RT
    Bone Marrow Transplant; 1995 Jun; 15(6):993-5. PubMed ID: 7581104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unusual presentation of dermatomyositis: the type Wong variant revisited.
    Lupton JR; Figueroa P; Berberian BJ; Sulica VI
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 2):908-12. PubMed ID: 11044819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary embolism induced by methotrexate in a dermatomyositis patient.
    Benzaquen M; Rouby F; Bobot M; Lebowitz D; Serratrice J; Belenotti P
    Joint Bone Spine; 2017 Jul; 84(4):501-502. PubMed ID: 27659404
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated epidermolytic acanthoma with disseminated superficial porokeratosis and verruca vulgaris in an immunosuppressed patient.
    Chun SI; Lee JS; Kim NS; Park KD
    J Dermatol; 1995 Sep; 22(9):690-2. PubMed ID: 8537558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis.
    High WA; Cohen JB; Murphy BA; Costner MI
    J Am Acad Dermatol; 2003 Aug; 49(2):295-8. PubMed ID: 12894081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis: report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders.
    Freyschmidt-Paul P; Hoffmann R; König A; Happle R
    J Am Acad Dermatol; 1999 Oct; 41(4):644-7. PubMed ID: 10495390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porokeratosis in Singapore: an Asian perspective.
    Tan LS; Chong WS
    Australas J Dermatol; 2012 May; 53(2):e40-4. PubMed ID: 22571584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperkeratotic variant of porokeratosis in a patient with Hepatitis C virus infection and a concomitant immunosuppressed state.
    Parekh V; Kabihting FD; Junkins-Hopkins JM
    Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-resolution of Epstein-Barr virus-associated B-cell lymphoma in a patient with dermatomyositis following withdrawal of mycophenolate mofetil and methotrexate.
    Waldman MA; Callen JP
    J Am Acad Dermatol; 2004 Aug; 51(2 Suppl):S124-30. PubMed ID: 15280831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis.
    Orden AO; Chuluyan JC; Colombini AC; Barbera RF
    Rheumatol Int; 2012 Jan; 32(1):273-5. PubMed ID: 21243491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy.
    Weiss VC; Serushan M
    Arch Dermatol; 1982 Mar; 118(3):183-5. PubMed ID: 7065668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of disseminated superficial porokeratosis in a patient with chronic graft-versus-host disease.
    Irie K
    Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147681
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple eruptive dermatofibromas in a patient with dermatomyositis taking prednisolone and methotrexate.
    Huang PY; Chu CY; Hsiao CH
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S81-4. PubMed ID: 17097372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.